Home › Funds › Renaissance Technologies › GLPG
Renaissance Technologies position in GLPG
LAKEFRONT BIOTHERAPEUTICS NV
Latest position (Q1 2026)315.40K sh
Reported value held$9.46M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 50.90K | $2.68M | New |
| Q4 2021 | 56.60K | $3.12M | Add |
| Q1 2022 | 84.50K | $5.24M | Add |
| Q2 2022 | 248.30K | $13.86M | Add |
| Q3 2022 | 298.60K | $12.73M | Add |
| Q4 2022 | 336.38K | $14.93K | Add |
| Q1 2023 | 358.40K | $13.85K | Add |
| Q2 2023 | 307.90K | $12.52K | Reduce |
| Q3 2023 | 281.80K | $9.74K | Reduce |
| Q4 2023 | 263.20K | $10.70K | Reduce |
| Q1 2024 | 266.50K | $8.58K | Add |
| Q2 2024 | 270.80K | $6.71M | Add |
| Q3 2024 | 291.68K | $8.40M | Add |
| Q4 2024 | 296.10K | $8.14M | Add |
| Q1 2025 | 330.80K | $8.31M | Add |
| Q1 2025 | 330.80K | $8.31M | Add |
| Q2 2025 | 464.70K | $13.01M | Add |
| Q2 2025 | 464.70K | $13.01M | Add |
| Q3 2025 | 356.20K | $12.34M | Reduce |
| Q4 2025 | 310.60K | $10.16M | Reduce |
| Q1 2026 | 315.40K | $9.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLPG
- BlackRock Inc 338.15K sh · $10.14M · Q2 2026
- D. E. Shaw & Co 197.84K sh · $5.93M · Q2 2026
- Millennium Management 181.09K sh · $5.43M · Q2 2026
- Two Sigma Investments 81.75K sh · $2.45M · Q2 2026
- Morgan Stanley 37.68K sh · $1.13M · Q2 2026
- Marshall Wace 32.40K sh · $971.32K · Q2 2026
- Geode Capital Management 10.15K sh · $304.30K · Q2 2026
- JPMorgan Chase & Co 1.32K sh · $39.16K · Q2 2026
- Wells Fargo & Co 1.20K sh · $35.98K · Q2 2026
- Citigroup Inc 354 sh · $10.61K · Q2 2026
- Fidelity Management & Research (FMR) 1 sh · $30 · Q2 2026